Rapid release testing detects mycoplasma DNA with great sensitivity by using advanced technologies such nucleic acid ...
Political bluster about vaccines has arrived along with the season for getting vaccinated against diseases that can lead to ...
Trained immunity represents a recent concept that elucidates the long-term reprogramming of innate immune cells, enabling them to adapt and respond more effectively to subsequent encounters with ...
Respiratory syncytial virus (RSV) is a well-known cause of infections in children, but it’s understudied in older individuals. In a retrospective study published in the Journal of the American ...
The researchers conducted a retrospective analysis of 188,721 hospitalized patients in Veterans Affairs (VA) hospitals across the United States from 2015 to 2025. “We know that people often get ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) ...
1 Institute of Infection, Immunology and Tumor Microenvironment, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Medical College, Wuhan University of Science and ...
The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 cause of hospitalization in infants. The US Food and Drug Administration ...
ENFLONSIA is a preventive monoclonal antibody designed to protect infants against a spectrum of RSV disease severity, including worsening disease requiring hospitalization ENFLONSIA is the first and ...
A single dose of the recombinant respiratory syncytial virus (RSV) vaccine demonstrates effectiveness against infections and associated hospitalizations in veterans aged 60 years or older during the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback